Ecstacy for PTSD The Multidisciplinary Association for Psychedelic Studies (MAPS) Project /
Ecstacy (MDMA) is in Phase 2 FDA trials for use as a therapeutic aid for people suffering from post-traumatic stress disorder. In this video, Multidisciplinary Association for Psychedelic Studies (MAPS) Project founder Rick Doblin and psychiatrist Michael Mithoefer talk about the results so far and...
| Other Authors: | Infobase,, Reason Foundation. |
|---|---|
| Format: | Video |
| Language: | English |
| Published: |
[Place of publication not identified] :
The Reason Foundation,
[2014]
Distributed by Infobase, |
| Physical Description: |
1 online resource (1 video file (6 min., 37 sec)) : sound, color. |
| Series: |
Multidisciplinary Association for Psychedelic Studies (MAPS) Project.
|
| Subjects: |
CMU Electronic Access
Electronic Resource Click Here| Location | Call Number: | Status |
|---|---|---|
| CMU Electronic Access | Available |